#CRCTrialsChat #VideoShorts 9/29/24 KRAS G12Ci combi — Dr. Parseghian
This blog is adapted from the #CRCTrialsChat session with short videos shared on September 29, 2024.
This 1st video introduces Dr @ParseghianC. It tells us a little bit about how she got into #GIOncology.https://t.co/6gFBpv2pNi
— #CRCTrialsChat (@CrcTrialsChat) September 29, 2024
Watch the 9 other #CRCTrialsChat #videoshorts posts to learn more about this #KRAS #G12Ci combi #clinicaltrial @OncoAlert @ThanksCancer @SU2Cscience
This 2nd video introduces the #KRAS #G12Ci combi trial for #StageIV #MSS #CRC. This is for patients who have progressed on 2L of treatment.https://t.co/8moTN3Lpei
— #CRCTrialsChat (@CrcTrialsChat) September 29, 2024
Watch the 9 other #CRCTrialsChat #videoshorts posts to learn more about this #clinicaltrial @OncoAlert @SU2Cscience
This video covers the rationale behind combining the drugs ( adagrasib+Cetux+Cemiplimab) in this #KRAS #G12Ci combi #clinicaltrial.https://t.co/hxtgWkrr23
— #CRCTrialsChat (@CrcTrialsChat) September 29, 2024
Watch the 9 other #CRCTrialsChat #videoshorts posts to learn more about this #clinicaltrial @OncoAlert @SU2Cscience #CRCSM
This video tell us what the #CRC #KRAS #G12Ci Combi #clinicaltrial aims to accomplish.https://t.co/wImsj9YzQm
— #CRCTrialsChat (@CrcTrialsChat) September 29, 2024
Watch the other (9) #CRCTrialsChat #videoshorts posts to learn more about this #clinicaltrial and the context around this video. @OncoAlert @SU2Cscience
This video tells us why this #CRC #KRAS #G12Ci Combi #clinicaltrial for MSS Stage IV CRC is important.
— #CRCTrialsChat (@CrcTrialsChat) September 29, 2024
If you are a patient with KRAS G12C mutation, watch thishttps://t.co/VWSD6fFulf
Don't forget to watch the other (9) #CRCTrialsChat #videoshorts posts in this thread@OncoAlert
This video tells us about the patients eligible for #CRC #KRAS #G12Ci Combi #clinicaltrial.
— #CRCTrialsChat (@CrcTrialsChat) September 29, 2024
If you are a patient with KRAS G12C mutation, watch this.https://t.co/f0gNMD1mWo
Don't forget to watch the other (9) #CRCTrialsChat #videoshorts posts in this thread@OncoAlert @SU2C
This #CRCTrialsChat #VideoShorts goes a bit more into the details of drugs in this #CRC #KRASG12Ci combi trialhttps://t.co/h1paVqhfAm
— #CRCTrialsChat (@CrcTrialsChat) September 29, 2024
Don't forget to watch the other (9) posts in this thread if you are a patient with a KRAS G12C mutated Stage IV MSS CRC@OncoAlert @SU2C
This #CRCTrialsChat #VideoShorts goes a bit more into the gap this #CRC #KRASG12Ci combi trial is trying to fill.https://t.co/vsWH1cpn4r
— #CRCTrialsChat (@CrcTrialsChat) September 29, 2024
Don't forget to watch the other (9) posts in this thread if you are a patient with a KRAS G12C mutated Stage IV MSS CRC@OncoAlert @SU2C
What do you need as a #CRC patient to be part of this trial? You need to know your KRAS status. Get tested!https://t.co/bgSbrIucF9
— #CRCTrialsChat (@CrcTrialsChat) September 29, 2024
Don't forget to watch the other (9) posts in this thread if you are a patient with a KRAS G12C mutated Stage IV MSS CRC@OncoAlert @SU2C #CRCSM
Of course, trials like this are not possible without funding!
— #CRCTrialsChat (@CrcTrialsChat) September 29, 2024
In this 🎬 Dr @ParseghianC tells us about the role of @SU2C & @SU2Cscience funding this trialhttps://t.co/r7Uch8ld5z
If you 💙 this #VideoShorts format, please like & retweet & follow @CRCTrialsChat
TY for watching!